Telehealth has the potential to improve health care access and reduce disparities. We examined whether the density of medical cannabis (MC) patients, stratified by those who were seen by a telemedicine provider or not, is associated with a concentrated disadvantage within Pennsylvania in 2022. This zip code-level analysis assessed associations between the concentrated disadvantage index (CDI) and counts of telemedicine-approved and all other MC patients.
View Article and Find Full Text PDFIntroduction: Research on the benefits of medical cannabis (MC) is emerging and supports its use as a treatment for post-traumatic stress disorder (PTSD). This study aimed to evaluate the cost effectiveness of MC as an adjunctive therapy for moderate PTSD under varying reimbursement scenarios.
Methods: A cost-utility analysis was conducted from the US payor perspective, using pricing data from the largest multi-state MC producer and established literature on standard PTSD treatments.